Vivek Ramaswamy's Insider Trades & SAST Disclosures

Vivek Ramaswamy's most recent trade in Roivant Sciences Ltd was a trade of 13,357,857 Common Shares done . Disclosure was reported to the exchange on Jan. 23, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Roivant Sciences Ltd
Vivek Ramaswamy Ten Percent Owner Gift of securities by or to the insider at price $ 0.00 per share. 23 Jan 2025 13,357,857 13,357,857 - 0 Common Shares
Roivant Sciences Ltd
Vivek Ramaswamy Ten Percent Owner Gift of securities by or to the insider at price $ 0.00 per share. 23 Jan 2025 13,357,857 40,073,570 - 0 Common Shares
Roivant Sciences Ltd
Ramaswamy Vivek Ten Percent Owner Sale of securities on an exchange or to another person at price $ 11.05 per share. 02 Jan 2024 3,000,000 51,929,426 - 11.1 33,150,000 Common Shares
Roivant Sciences Ltd
Ramaswamy Vivek Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Dec 2023 611,393 7,132,921 - - Capped Value Appreciation Rights
Roivant Sciences Ltd
Ramaswamy Vivek Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Dec 2023 275,227 55,063,337 - - Common Shares
Roivant Sciences Ltd
Ramaswamy Vivek Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Dec 2023 251,538 11,570,769 - - Capped Value Appreciation Rights
Roivant Sciences Ltd
Ramaswamy Vivek Ten Percent Owner Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.58 per share. 27 Dec 2023 133,911 54,929,426 - 11.6 1,550,689 Common Shares
Roivant Sciences Ltd
Vivek Ramaswamy Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Aug 2023 203,798 7,948,112 - - Capped Value Appreciation Rights
Roivant Sciences Ltd
Vivek Ramaswamy Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Aug 2023 86,714 54,778,215 - - Common Shares
Roivant Sciences Ltd
Vivek Ramaswamy Ten Percent Owner Other type of transaction at price $ 11.25 per share. 27 Aug 2023 47,692 54,730,523 - 11.3 536,535 Common Shares
Roivant Sciences Ltd
Vivek Ramaswamy Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Jul 2023 407,595 8,151,910 - - Capped Value Appreciation Rights
Roivant Sciences Ltd
Vivek Ramaswamy Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Jul 2023 166,057 54,767,524 - - Common Shares
Roivant Sciences Ltd
Vivek Ramaswamy Ten Percent Owner Other type of transaction at price $ 11.43 per share. 27 Jul 2023 76,023 54,691,501 - 11.4 868,943 Common Shares
Roivant Sciences Ltd
Vivek Ramaswamy Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 May 2023 1,222,787 8,559,505 - - Capped Value Appreciation Rights
Roivant Sciences Ltd
Vivek Ramaswamy Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 May 2023 382,203 54,791,414 - - Common Shares
Roivant Sciences Ltd
Vivek Ramaswamy Ten Percent Owner Other type of transaction at price $ 9.09 per share. 27 May 2023 189,947 54,601,467 - 9.1 1,726,618 Common Shares
Roivant Sciences Ltd
Vivek Ramaswamy Director Sale of securities on an exchange or to another person at price $ 7.95 per share. 22 Feb 2023 4,000,000 54,409,211 - 8.0 31,800,000 Common Shares
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades